Jellagen company

Collagen-based innovation that addresses complex tissue engineering and regenerative medical needs, helping to shape next-generation medical treatments alongside current and future scientific research.

Last Funding Type: Series B
Funding Status: Early Stage Venture
Headquarters: Pembroke Dock, Pembrokeshire, United Kingdom
Founded Date: 7-5
Investor Type: Company
Investment Stage: N/A
Total Funding: £5.7M
Technology: Regenerative Medicine
Employee Number: 1-10
Number Of Exists: Series B
Estimated Revenue: $1M to $10M
Investors Number: 5
Industry: Regenerative Medicine